Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Biogen Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 223,632 shares of BIIB stock, worth $31.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

223,632

Previous 203,096 10.11%

Holding current value

$31.4 Million

Previous $47.1 Million 7.93%

% of portfolio

0.05%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$189.07 - $236.8 $3.88 Million - $4.86 Million	20,536 Added 10.11%	223,632 $43.3 Million
Q2 2024 Aug 12, 2024	BUY	$190.52 - $236.72 $4.51 Million - $5.6 Million	23,677 Added 13.2%	203,096 $47.1 Million
Q1 2024 May 09, 2024	BUY	$212.02 - $267.71 $6.36 Million - $8.03 Million	29,991 Added 20.07%	179,419 $38.7 Million
Q4 2023 Feb 08, 2024	BUY	$222.59 - $267.94 $1.71 Million - $2.06 Million	7,683 Added 5.42%	149,428 $38.7 Million
Q3 2023 Nov 07, 2023	BUY	$253.3 - $285.89 $3.54 Million - $4 Million	13,974 Added 10.94%	141,745 $36.4 Million
Q2 2023 Aug 09, 2023	BUY	$275.25 - $318.06 $2.26 Million - $2.61 Million	8,195 Added 6.85%	127,771 $36.4 Million
Q1 2023 May 08, 2023	BUY	$256.56 - $292.34 $2.08 Million - $2.37 Million	8,107 Added 7.27%	119,576 $33.2 Million
Q4 2022 Feb 07, 2023	BUY	$252.44 - $306.72 $3.48 Million - $4.23 Million	13,781 Added 14.11%	111,469 $30.9 Million
Q3 2022 Nov 01, 2022	BUY	$194.69 - $268.46 $1.42 Million - $1.96 Million	7,291 Added 8.07%	97,688 $26.1 Million
Q2 2022 Aug 04, 2022	BUY	$187.54 - $223.02 $1.09 Million - $1.3 Million	5,831 Added 6.9%	90,397 $18.4 Million
Q1 2022 May 09, 2022	BUY	$193.77 - $244.14 $1.32 Million - $1.66 Million	6,801 Added 8.75%	84,566 $17.8 Million
Q4 2021 Feb 07, 2022	BUY	$223.92 - $287.77 $2.41 Million - $3.1 Million	10,774 Added 16.08%	77,765 $19 Million
Q3 2021 Nov 04, 2021	BUY	$282.99 - $369.05 $2.01 Million - $2.62 Million	7,095 Added 11.85%	66,991 $19 Million
Q2 2021 Aug 06, 2021	BUY	$259.0 - $414.71 $1.62 Million - $2.59 Million	6,239 Added 11.63%	59,896 $20.7 Million
Q1 2021 May 06, 2021	BUY	$242.95 - $284.63 $1.49 Million - $1.74 Million	6,117 Added 12.87%	53,657 $15 Million
Q4 2020 Feb 09, 2021	BUY	$236.26 - $355.63 $167,744 - $252,497	710 Added 1.52%	47,540 $11.6 Million
Q3 2020 Nov 10, 2020	BUY	$264.77 - $305.71 $735,531 - $849,262	2,778 Added 6.31%	46,830 $13.3 Million
Q2 2020 Aug 06, 2020	BUY	$258.66 - $342.55 $1.09 Million - $1.44 Million	4,214 Added 10.58%	44,052 $11.8 Million
Q1 2020 May 11, 2020	SELL	$268.85 - $341.04 $333,642 - $423,230	-1,241 Reduced 3.02%	39,838 $12.6 Million
Q4 2019 Feb 05, 2020	BUY	$220.06 - $304.07 $1.11 Million - $1.53 Million	5,026 Added 13.94%	41,079 $11.9 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $151,990 - $170,472	699 Added 1.98%	36,053 $8.39 Million
Q2 2019 Aug 08, 2019	BUY	$219.29 - $241.72 $1.42 Million - $1.57 Million	6,497 Added 22.51%	35,354 $8.27 Million
Q1 2019 Apr 26, 2019	BUY	$216.71 - $338.96 $381,409 - $596,569	1,760 Added 6.5%	28,857 $6.82 Million
Q4 2018 Feb 08, 2019	SELL	$278.5 - $352.75 $912,644 - $1.16 Million	-3,277 Reduced 10.79%	27,097 $8.32 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $542,993 - $710,085	-1,850 Reduced 5.74%	30,374 $10.7 Million
Q2 2018 Aug 09, 2018	SELL	$257.52 - $306.91 $2.4 Million - $2.86 Million	-9,327 Reduced 22.45%	32,224 $9.35 Million
Q1 2018 May 02, 2018	BUY	$260.13 - $367.91 $1.75 Million - $2.47 Million	6,711 Added 19.26%	41,551 $11.4 Million
Q4 2017 Feb 06, 2018	BUY	$307.64 - $344.58 $92,907 - $104,063	302 Added 0.87%	34,840 $11.8 Million
Q3 2017 Nov 01, 2017	BUY	$281.15 - $329.69 $9.71 Million - $11.4 Million	34,538	34,538 $10.8 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

126M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account

Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Biogen Inc. Transaction History